DOCSLIB.ORG

Phosphonate and Phosphinate Compounds As

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Phosphonate and Phosphinate Compounds As (19) TZZ Z _T (11) EP 2 059 522 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07F 9/32 (2006.01) C07F 9/40 (2006.01) 08.01.2014 Bulletin 2014/02 A61K 31/675 (2006.01) A61P 3/00 (2006.01) (21) Application number: 07812578.8 (86) International application number: PCT/US2007/072708 (22) Date of filing: 03.07.2007 (87) International publication number: WO 2008/005964 (10.01.2008 Gazette 2008/02) (54) PHOSPHONATE AND PHOSPHINATE COMPOUNDS AS GLUCOKINASE ACTIVATORS PHOSPHONAT- UND PHOSPHINATVERBINDUNGEN ALS GLUCOKINASE-AKTIVATOREN DERIVES DE PHOSPHONATE ET DE PHOSPHINATE EN TANT QU’ACTIVATEURS DE LA GLUCOKINASE (84) Designated Contracting States: (74) Representative: Beacham, Annabel Rose AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Dehns HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE St Bride’s House SI SK TR 10 Salisbury Square Designated Extension States: London HR EC4Y 8JD (GB) (30) Priority: 06.07.2006 US 818912 P (56) References cited: 28.06.2007 US 769964 EP-A- 1 074 556 WO-A-2004/013139 WO-A2-2006/063194 (43) Date of publication of application: 20.05.2009 Bulletin 2009/21 • HOLY A ET AL: "SYNTHESIS OF N-(2- PHOSPHONYLMETHOXYETHYL) DERIVATIVES (73) Proprietor: Bristol-Myers Squibb Company OF HETEROCYCLIC BASES" COLLECTION OF Princeton, NJ 08543-4000 (US) CZECHOSLOVAK CHEMICAL COMMUNICATIONS, INSTITUTE OF ORGANIC (72) Inventors: CHEMISTRY & BIOCHEMISTRY, PRAGUE, CZ, • RYONO, Dennis E. vol. 54, no. 8, 1989, pages 2190-2210, Princeton, NJ 08540 (US) XP008046015 ISSN: 0010-0765 • CHENG, Peter T.W. • ENDOVA M ET AL: "TRANSPROTECTION OF N- Pennington, NJ 08534 (US) BENZOYLATED NUCLEOBASE DERIVATIVES •BOLTON,Scott A. BY DIALKYLAMINOMETHYLENE GROUP" Pennington, NJ 08534 (US) NUCLEOSIDES & NUCLEOTIDES, MARCEL • CHEN, Sean S. DEKKER, INC, US, vol. 16, no. 12, 1997, pages Pennington, NJ 08534 (US) 2151-2164, XP000876719 ISSN: 0732-8311 • SHI, Yan • BABOULENE M ET AL: "Reactivity of diethyl 3- Pennington, NJ 08534 (US) bromo-2-oxopropylphosphonate in the Hantzsch •MENG,Wei reaction.(Reactivite du bromo-3 oxo-2 propyl Pennington, NJ 08534 (US) phosphonate de diethyle dans la reaction de • TINO, Joseph A. hantzsch)" PHOSPHORUS AND SULFUR AND Pennington, NJ 08534 (US) THE RELATED ELEMENTS, GORDON AND • ZHANG, Hao BREACH - HARWOOD ACADEMIC, CH, vol. 5, no. Pennington, NJ 08534 (US) 1, 1978, pages 87-94, XP009093025 ISSN: • SULSKY, Richard B. 0308-664X Pennington, NJ 08534 (US) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 2 059 522 B1 Printed by Jouve, 75001 PARIS (FR) (Cont. next page) EP 2 059 522 B1 • ROSENBERG I ET AL: "Acyclic nucleotide • DANG Q: "Organophosphonic acids as drug analogs. IV. Phosphonylmethoxyalkyl and candidates", EXPERT OPINION ON phosphonylalkyl derivatives of adenine" THERAPEUTIC PATENTS 200603 GB LNKD- DOI: COLLECTION OF CZECHOSLOVAK CHEMICAL 10.1517/13543776.16.3.343, vol. 16, no. 3, March COMMUNICATIONS, INSTITUTE OF ORGANIC 2006 (2006-03), pages 343-348, ISSN: 1354-3776 CHEMISTRY & BIOCHEMISTRY, PRAGUE, CZ, vol. 53, 1988, pages 2753-2777, XP002116171 ISSN: 0010-0765 • RUMTHAO S ET AL: "Design, synthesis, and evaluation of oxyanion-hole selective inhibitor substituents for the S1 subsite of factor Xa" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 14, no. 20, 18 October 2004 (2004-10-18), pages 5165-5170, XP004565453 ISSN: 0960-894X 2 EP 2 059 522 B1 Description FIELD OF THE INVENTION 5 [0001] The present invention relates to novel phosphonate and phosphinate compounds which are activators of the enzyme glucokinase and thus are useful in treating diabetes, and to such compounds for use in treating diabetes, especially Type II diabetes. BACKGROUND OF THE INVENTION 10 [0002] The enzyme glucokinase (GK), which is mainly found in pancreatic β-cells and liver parenchymal cells, catalyzes the conversion of glucose to glucose-6-phosphate, which is the first step in the metabolism of glucose. Glucokinase is also a rate-controlling enzyme for glucose metabolism in pancreatic β-cells and liver parenchymal cells, which play an important role in whole-body glucose homeostasis. 15 [0003] Liag, Y. et al., (Biochem. J., 1995, 309:167-173) report the finding that Type II (maturity-onset) diabetes of the young (MODY-2) is caused by loss of function mutations in the glucokinase gene, which suggests that glucokinase also functions as a glucose sensor in humans. Thus, compounds that activate glucokinase and thus increase the sensitivity of the glucokinase sensor system and thereby cause increase in insulin secretion will be useful in the treatment of hyperglycemia and Type II diabetes. 20 [0004] Glucokinase activators have been demonstrated to be effective in enhancing: 1) the effect of glucose on insulin release from isolated rat and human pancreatic islets, and 2) the glucose induction of pancreatic islet glucokinase in isolated cultured rat islets (e.g. Matschinsky, F.M. et al., Diabetes, 2006, 55: 1, and ("Glucokinase and Glycemic Disease, from Basics to Novel Therapeutics", published by Karger, 2004; F.M. Matschinsky and M.A. Magnuson, eds., Ch. 6, pp. 360-378). In diabetic animal model studies, glucokinase activators have been demonstrated to stimulate insulin release, 25 enhance glycogen synthesis and reduce hepatic glucose production in pancreatic clamp studies. Importantly, glucokinase activators have been demonstrated to dose- dependently lower blood glucose levels in different standard animal models of type 2 diabetes, such as the ob/ob mouse, db/db mouse and Zucker in acute single- dose studies and also effectively improved the glucose excursion in both normal C57/BL6J and ob/ob mice in oral glucose tolerance tests (e.g. in "Glu- cokinase and Glycemic Disease, from Basics to Novel Therapeutics", published by Karger, 2004; F.M. Matschinsky and 30 M.A. Magnuson, eds., Ch. 6, pp. 360-378 as well as Fyfe, M.C. et al., Diabetologia, 2007, 50: 1277). [0005] Glucokinase activators have also demonstrated antidiabetic efficacv in chronic animal models of type II diabetes. For instance, in a 9-day study in ob/ob mice, a glucokinase activator improved the overall glucose profile while showing comparable antihyperglycemic effects in oral glucose tolerance tests at the beginning and end of the study (Fyfe, M.C. et al., Diabetologia, 2007, 50: 1277). In another instance, in a chronic 40-week study, a glucokinase activator prevented 35 the development of hyperglycemia in diet-induced obese mice which were glucose intolerant. The diet-induced obese mice treated with a glucokinase activator showed marked improvement in the glucose excursion in an oral glucose tolerance test at the end of the study relative to the control group ("Glucokinase and Glycemic Disease, from Basics to Novel Therapeutics", published by Karger, 2004; F.M. Matschinskv and M.A. Magnuson, eds., Ch. 6, pp. 360-378). [0006] Glucokinase activators are reported in WO2004/063194. 40 SUMMARY OF THE INVENTION [0007] In accordance with one aspect of the invention, compounds are provided having the structure I 45 50 wherein the moiety 55 3 EP 2 059 522 B1 5 is 10 15 20 substituted by R4 and optionally substituted with one or two substituents R 5 and R6; R4 is selected from the group consisting of 25 30 35 40 R5 and R6 are the same or different and are independently selected from hydrogen, C 1-8 alkyl, halogen or carboxyl, or is absent; 45 Y-X-CO- is 50 55 4 EP 2 059 522 B1 5 10 or Y-X-CO- is 15 20 25 or Y-X-CO- is 30 35 40 ; or Y-X-CO- is 45 50 55 or 5 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 55 6 EP 2 059 522 B1 5 10 or 15 Y-X-CO- is 20 25 a compound selected from 30 35 40 45 50 55 7 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 55 8 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 or 55 9 EP 2 059 522 B1 5 10 all stereoisomers thereof, or a pharmaceutically acceptable salt thereof. [0008] Examples of preferred compounds in accordance with the present invention include, but are not limited to, the 15 following: 20 25 30 35 40 45 50 55 10 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 55 11 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 55 12 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 55 13 EP 2 059 522 B1 5 10 15 20 25 30 35 40 45 50 55 14 EP 2 059 522 B1 5 10 [0009] The compounds of the present invention activate or enhance the activity of the enzyme glucokinase. Conse- quently, the compounds of the present invention may be used in the treatment of multiple diseases or disorders associated 15 with a deficit of glucokinase, such as diabetes and related conditions, microvascular complications associated with diabetes, the macrovascular complications associated with diabetes, cardiovascular diseases, Metabolic Syndrome and its component conditions, and other maladies. Examples of diseases or disorders associated with deficit in activity of the enzyme glucokinase that can be prevented, inhibited, or treated according to the present invention include, but are not limited to, diabetes, hyperglycemia, impaired glucose tolerance, insulin resistance, hyperinsulinemia, retinopathy, 20 neuropathy, nephropathy, delayed wound healing, atherosclerosis and its sequelae, abnormal heart function, myocardial ischemia, stroke, Metabolic Syndrome, hypertension, obesity, dyslipidemia, hyperlipidemia, hypertriglyceridemia, hy- percholesterolemia, low HDL, high LDL, non- cardiac ischemia, infection, cancer, vascular restenosis, pancreatitis, neu- rodegenerative disease, lipid disorders, cognitive impairment and dementia, bone disease, HIV protease associated lipodystrophy, and glaucoma.
Load more

Recommended publications
  • Asymmetric Synthesis of Organophosphates and Their
    ASYMMETRIC SYNTHESIS OF ORGANOPHOSPHATES AND THEIR DERIVATIVES Thesis Submitted to The College of Arts and Sciences of the UNIVERSITY OF DAYTON In Partial Fulfillment of the Requirements for The Degree of Master of Science in Chemistry By Batool J. Murtadha Dayton, Ohio May 2020 ASYMMETRIC SYNTHESIS OF ORGANOPHOSPHATES AND THEIR DERIVATIVES Name: Murtadha, Batool J. APPROVED BY: __________________________________ Jeremy Erb, Ph.D. Research Advisor Assistant Professor Department of Chemistry University of Dayton ___________________________________ Vladimir Benin, Ph.D. Professor of Chemistry Department of Chemistry University of Dayton ___________________________________ Justin C. Biffinger, Ph.D. Committee Member Assistant Professor Department of Chemistry University of Dayton ii © Copyright by Batool J. Murtadha All rights reserved 2020 iii ABSTRACT ASYMMETRIC SYNTHESIS OF ORGANOPHOSPHATES AND THEIR DERIVATIVES Name: Murtadha, Batool J. University of Dayton Advisor: Dr. Jeremy Erb Organophosphorus compounds (OPs) are widely used in the agricultural industry especially in the pesticide market. Phosphates play a huge role as biological compounds in the form of energy carrier compounds like ATP, and medicine as antivirals. OPs have become increasingly important as evidenced by the publication of new methods devoted to their uses and synthesis. These well-established studies lay the basis for industrial organic derivatives of phosphorus preparations. The current work explored methods of synthesizing chiral organophosphate triesters. We experimented with different processes roughly divided into either an electrophilic or nucleophilic strategy using chiral Lewis acids, organocatalysts (HyperBTM), activating agents, and chiral auxiliaries with the goal of control stereoselectivity. These methods were explored through the use of different starting materials like POCl3, triethyl phosphate, methyl phosphordichloradate, and PSCl3.
    [Show full text]
  • Qsar Analysis of the Chemical Hydrolysis of Organophosphorus Pesticides in Natural Waters
    QSAR ANALYSIS OF THE CHEMICAL HYDROLYSIS OF ORGANOPHOSPHORUS PESTICIDES IN NATURAL WATERS. by Kenneth K. Tanji Principal Investigator and Jonathan 1. Sullivan Graduate Research Assistant Department of Land, Air and Water Resources University of California, Davis Technical Completion Report Project Number W-843 August, 1995 University of California Water Resource Center The research leading to this report was supported by the University of California Water Resource Center as part of Water Resource Center Project W-843. Table of Contents Page Abstract 2 Problem and Research Objectives 3 Introduction 5 Theoretical Background 6 QSAR Methodology 7 Molecular Connectivity Theory 8 Organophosphorus Pesticides 12 Experimental Determination of Rates 15 Results and Discussion 17 Principal Findings and Significance 19 References 34 List of Tables Page Table 1. Statistical relationship between OP pesticides and first-order MC/'s. 30 Table 2. Inherent conditions of waters used in experimental work. 16 Table 3. Estimated half-lives for organophosphorus esters derived from model. 31 Table 4. Half-lives and first-order MCI' sfor model calibration data set. 31 Table 5. Experimental kinetic data for validation set compounds, Sacramento. 33 List of Figures Page Figure 1. Essential Features OfQSAR Modeling Methodology. 21 Figure 2. Regression plot for In hydrolysis rate vs. 1st order MCl' s. 22 Figure 3. a 3-D molecular model, a line-segment model and a graphical model. 23 Figure 4. Molecular connectivity index suborders. 24 Figure 5. Chlorpyrifos and its fourteen fourth order path/cluster fragments. 25 Figure 6. Abridged MClndex output. 26 Figure 7. Parent acids of most common organophosphorus pesticides. 12 Figure 8.
    [Show full text]
  • The Hydrolysis of Phosphinates and Phosphonates: a Review
    molecules Review The Hydrolysis of Phosphinates and Phosphonates: A Review Nikoletta Harsági and György Keglevich * Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1521 Budapest, Hungary; [email protected] * Correspondence: [email protected]; Tel.: +36-1-463-1111 (ext. 5883) Abstract: Phosphinic and phosphonic acids are useful intermediates and biologically active com- pounds which may be prepared from their esters, phosphinates and phosphonates, respectively, by hydrolysis or dealkylation. The hydrolysis may take place both under acidic and basic conditions, but the C-O bond may also be cleaved by trimethylsilyl halides. The hydrolysis of P-esters is a challenging task because, in most cases, the optimized reaction conditions have not yet been explored. Despite the importance of the hydrolysis of P-esters, this field has not yet been fully surveyed. In order to fill this gap, examples of acidic and alkaline hydrolysis, as well as the dealkylation of phosphinates and phosphonates, are summarized in this review. Keywords: hydrolysis; dealkylation; phosphinates; phosphonates; P-acids 1. Introduction Phosphinic and phosphonic acids are of great importance due to their biological activity (Figure1)[ 1]. Most of them are known as antibacterial agents [2,3]. Multidrug- resistant (MDR) and extensively drug-resistant (XDR) pathogens may cause major problems Citation: Harsági, N.; Keglevich, G. in the treatment of bacterial infections. However, Fosfomycin has remained active against The Hydrolysis of Phosphinates and both Gram-positive and Gram-negative MDR and XDR bacteria [2]. Acyclic nucleoside Phosphonates: A Review. Molecules phosphonic derivatives like Cidofovir, Adefovir and Tenofovir play an important role 2021, 26, 2840.
    [Show full text]
  • Recent Developments in Organophosphorus Flame Retardants Containing P-C Bond and Their Applications
    materials Review Recent Developments in Organophosphorus Flame Retardants Containing P-C Bond and Their Applications Sophie Wendels †, Thiebault Chavez †, Martin Bonnet, Khalifah A. Salmeia * and Sabyasachi Gaan * Additives and Chemistry Group, Advanced Fibers, Empa, Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland; [email protected] (S.W.); [email protected] (T.C.); [email protected] (M.B.) * Correspondence: [email protected] (K.A.S.); [email protected] (S.G.); Tel.: +41-587-657-038 (K.A.S.); +41-587-657-611 (S.G.) † These two authors contributed equally to this work. Received: 13 May 2017; Accepted: 4 July 2017; Published: 11 July 2017 Abstract: Organophosphorus compounds containing P-C bonds are increasingly developed as flame retardant additives due to their excellent thermal and hydrolytic stability and ease of synthesis. The latest development (since 2010) in organophosphorus flame retardants containing P-C bonds summarized in this review. In this review, we have broadly classified such phosphorus compounds based on the carbon unit linked to the phosphorus atom i.e., could be a part of either an aliphatic or an aromatic unit. We have only considered those published literature where a P-C bond was created as a part of synthetic strategy to make either an intermediate or a final organophosphorus compound with an aim to use it as a flame retardant. General synthetic strategies to create P-C bonds are briefly discussed. Most popular synthetic strategies used for developing P-C containing phosphorus based flame retardants include Michael addition, Michaelis–Arbuzov, Friedels–Crafts and Grignard reactions.
    [Show full text]
  • Advanced Studies on the Synthesis of Organophosphorus Compounds
    ALMA MATER STUDIORUM UNIVERSITÀ DI BOLOGNA DOTTORATO DI RICERCA IN SCIENZE CHIMICHE (XIX° ciclo) Area 03 Scienze Chimiche-CHIM/06 Chimica Organica Dipartimento di Chimica Organica “A. Mangini” Coordinatore: Chiar.mo Prof. Vincenzo Balzani Advanced Studies on the Synthesis of Organophosphorus Compounds Dissertazione Finale Presentata da: Relatore: Dott. ssa Marzia Mazzacurati Prof. Graziano Baccolini Co-relatore: Dott.ssa Carla Boga INDEX Index: Keywords…………………………………………………………….………….VII Chapter 1…………………………………………………………………………..3 GENERAL INTRODUCTION ON PHOSPHORUS CHEMISTRY 1.1 Organophosphorus Chemistry………………………………………………….4 1.1.1 Phosphines………………………………………………………………..5 1.1.2 Phosphonates……………………………………………………………..6 1.1.3 Phosphites………………………………………………………………...7 1.2 Uses of Organophosphorus Compounds………………………………………..7 1.2.1 Agricultural Application………………………………………………….8 1.2.2 Catalysis……………………………………………………………..…....9 1.2.3 Organophosphorus Conpounds in Medicine…………………………….11 1.2.4 Phosphorus in Biological Compounds…………………………………..12 1.3 References……………………………………………………………………..15 Chapter 2…………………………………………………………………………17 THE HYPERCOORDINATE STATES OF PHOSPHORUS 2.1 The 5-Coordinate State of Phosphorus……………………………………….17 2.2 Pentacoordinated structures and their non rigid character…………………….18 2.3 Permutational isomerization…………………………………………………..19 2.3.1 Berry pseudorotation……………………………………………………20 2.3.2 Turnstile rotation………………………………………………………..21 2.4 The 6-Coordinate State of Phosphorus……………………………………….22 2.5 References…………………………………………………………………......24 I Chapter
    [Show full text]
  • Natural Products Containing 'Rare'
    Natural Products Containing ‘Rare’ Organophosphorus Functional Groups The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Petkowski, Janusz, et al. “Natural Products Containing ‘Rare’ Organophosphorus Functional Groups.” Molecules, vol. 24, no. 5, Feb. 2019, p. 866. As Published http://dx.doi.org/10.3390/molecules24050866 Publisher Multidisciplinary Digital Publishing Institute Version Final published version Citable link http://hdl.handle.net/1721.1/120918 Terms of Use Creative Commons Attribution Detailed Terms https://creativecommons.org/licenses/by/4.0/ molecules Review Natural Products Containing ‘Rare’ Organophosphorus Functional Groups Janusz J. Petkowski 1,* , William Bains 2 and Sara Seager 1,3,4 1 Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology, 77 Mass. Ave., Cambridge, MA 02139, USA; [email protected] 2 Rufus Scientific, 37 The Moor, Melbourn, Royston, Herts SG8 6ED, UK; [email protected] 3 Department of Physics, Massachusetts Institute of Technology, 77 Mass. Ave., Cambridge, MA 02139, USA 4 Department of Aeronautics and Astronautics, Massachusetts Institute of Technology, 77 Mass. Ave., Cambridge, MA 02139, USA * Correspondence: [email protected] Received: 21 January 2019; Accepted: 22 February 2019; Published: 28 February 2019 Abstract: Phosphorous-containing molecules are essential constituents of all living cells. While the phosphate functional group is very common in small molecule natural products, nucleic acids, and as chemical modification in protein and peptides, phosphorous can form P–N (phosphoramidate), P–S (phosphorothioate), and P–C (e.g., phosphonate and phosphinate) linkages. While rare, these moieties play critical roles in many processes and in all forms of life.
    [Show full text]
  • Organophosphorus Chemistry (Kanda, 2019)
    Baran lab Group Meeting Yuzuru Kanda Organophosphorus Chemistry 09/20/19 bonding and non-bonding MOs of PH3 bonding and non-bonding MOs of PH5 # of R P(III) ← → P(V) O P P R R R R R R phosphine phosphine oxide D3h C3v C2v O O JACS. 1972, 3047. P P P P R NH R OH R OH R NH Chem. Rev. 1994, 1339. R 2 R R R 2 D C phosphineamine phosphinite phosphinate phosphinamide 3h 4v O O O R P R P R P R P R P R P NH2 NH2 OH OH NH2 NH2 H2N HO HO HO HO H2N phosphinediamine phosphonamidite phosphonite phosphonate phosphonamidate phosphonamide O O O O H N P P P P P P P P 2 NH HO HO HO HO HO HO H2N H N 2 NH2 NH2 OH OH NH2 NH2 NH2 2 H2N HO HO HO HO H2N H2N phosphinetriamine phosphorodiamidite phosphoramidite phosphite phosphate phosphoramidate phosphorodiamidate phosphoramide more N O more O Useful Resources more N P P P Corbridge, D. E. C. Phosphorus: Chemistry, Biochemistry and H OH H H H H H H H Technology, 6th ed.; CRC Press Majoral, J. P. New Aspects In Phosphorus Chemistry III.; Springer phosphinous phosphane phosphane Murphy, P. J. Organophosphorus Reagents.; Oxford acid oxide Hartley, F. R. The chemistry of organophosphorus compounds, O O volume 1-3.; Wiley P P P Cadogan. J. I. G. Organophosphorus Reagents in Organic H OH H OH H OH HO HO H Synthesis.; Academic Pr phosphonate phosphonus acid phosphinate Not Going to Cover ↔ (phosphite) Related GMs Metal complexes, FLP, OPV Highlights in Peptide and Protein NH S R • oxidation state +5, +4, +3, +2, +1, 0, -1, -2, -3 Synthesis (Malins, 2016) R P-Stereogenic Compounds P P R P • traditionally both +3 and -3 are written as (III) R • 13/25th most abundant element on the earth (Rosen, 2014) R • but extremely rare outside of our solar system Ligands in Transition Metal phosphine imide phosphine sulfide phosphorane Catalysis (Farmer, 2016) Baran lab Group Meeting Yuzuru Kanda Organophosphorus Chemistry 09/20/19 Me P Me Me Low-Coordinate Low Oxidation State P tBu tBu P P phosphaalkyne R N P PivCl 2 P Me Cl TMS OTMS NaOH R = tBu Nb N tBu PTMS3 P O H O P NR2 then Na/Hg tBu N -2 Nb tBu R2N Me Nb N tBu 5x10 mbar, 160 ºC NR2 95% R2N Me N O 1.
    [Show full text]
  • Acscatal.0C01923.Pdf
    This is a repository copy of Phosphoranyl Radical Fragmentation Reactions Driven by Photoredox Catalysis. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/163811/ Version: Published Version Article: Rossi-Ashton, James A., Clarke, Aimee K., Unsworth, William P. orcid.org/0000-0002- 9169-5156 et al. (1 more author) (2020) Phosphoranyl Radical Fragmentation Reactions Driven by Photoredox Catalysis. ACS Catalysis. pp. 7250-7261. ISSN 2155-5435 https://doi.org/10.1021/acscatal.0c01923 Reuse This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the authors for the original work. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ This is an open access article published under a Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. pubs.acs.org/acscatalysis Perspective Phosphoranyl Radical Fragmentation Reactions Driven by Photoredox Catalysis James A. Rossi-Ashton,* Aimee K. Clarke, William P. Unsworth, and Richard J. K. Taylor Cite This: ACS Catal. 2020, 10, 7250−7261 Read Online ACCESS Metrics & More Article Recommendations ABSTRACT: Photocatalytic generation of phosphoranyl radicals is fast emerging as an essential method for the generation of diverse and valuable radicals, typically via deoxygenation or desulfurization processes.
    [Show full text]
  • Synthesis, Crystal Structure and Biological Evaluation of New
    Bioorganic Chemistry 86 (2019) 482–493 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Synthesis, crystal structure and biological evaluation of new phosphoramide T derivatives as urease inhibitors using docking, QSAR and kinetic studies ⁎ Khodayar Gholivanda, , Mahsa Pooyana, Fahimeh Mohammadpanaha, Foroogh Pirastefara, Peter C. Junkb, Jun Wangb, Ali Asghar Ebrahimi Valmoozia, Ahmad Mani-Varnosfaderania a Department of Chemistry, Faculty of Science, Tarbiat Modares University, Tehran, Iran b College of Science & Engineering, James Cook University, Townsville, Queensland 4811, Australia ARTICLE INFO ABSTRACT Keywords: In an attempt to achieve a new class of phosphoramide inhibitors with high potency and resistance to the Bisphosphoramide derivatives hydrolysis process against urease enzyme, we synthesized a series of bisphosphoramide derivatives (01–43) and Urease enzyme characterized them by various spectroscopic techniques. The crystal structures of compounds 22 and 26 were Inhibitory activity investigated using X-ray crystallography. The inhibitory activities of the compounds were evaluated against the Docking jack bean urease and were compared to monophosphoramide derivatives and other known standard inhibitors. Kinetics The compounds containing aromatic amines and their substituted derivatives exhibited very high inhibitory QSAR −10 activity in the range of IC50 = 3.4–1.91 × 10 nM compared with monophosphoramides, thiourea, and acetohydroxamic acid. It was also found that derivatives with P]O functional groups have higher anti-urease activity than those with P]S functional groups. Kinetics and docking studies were carried out to explore the binding mechanism that showed these compounds follow a mixed-type mechanism and, due to their extended structures, can cover the entire binding pocket of the enzyme, reducing the formation of the enzyme-substrate complex.
    [Show full text]
  • 5898031 52 US Cl...435/1723
    USOO5898.031A United States Patent (19) 11 Patent Number: 5,898,031 Crooke (45) Date of Patent: Apr. 27, 1999 54) OLIGORIBONUCLEOTIDES FOR CLEAVING 5,457,191 10/1995 Cook et al. .......................... 536/27.13 RNA 5,459,255 10/1995 Cook et al. .......................... 536/27.13 5,466,786 11/1995 Buhr et al. ...... ... 536/26.26 75 Inventor: Stanley T. Crooke, Carlsbad, Calif. 5,476.925 12/1995 Letsinger et al. ...................... 536/23.1 5,484,908 1/1996 Froehler et al. ..................... 536/24.31 5,489,677 2/1996 Sanghvi et al. ..... ... 53.6/2.2.1 73 ASSignee: sis Pharmaceuticals, Inc., Carlsbad, 5,506,337 4/1996 Summerton et al. ................... 528/391 a. 5,506,351 4/1996 McGee ................ 536/55.3 5,508,270 4/1996 Baxter et al. ... 514/47 21 Appl. No.: 08/659,440 5,514,786 5/1996 Cook et al.. 5,539,083 7/1996 Cook et al. ............................. 530/333 22 Filed: Jun. 6, 1996 FOREIGN PATENT DOCUMENTS 51) Int. Cl. ............................. C12N 15700; C12O 1/68; CO7H 21/04 339842 11/1989 European Pat. Off.. 52 U.S. Cl. ........................... 435/1723; 435/6, 435/375, WC. E. W.E. 536/23.1536/24.5• us WO 92/22651 12/1992 WIPO. 58 Field of Search .............................. 514/44; 536/23.1, WO 94/O2499 2/1994 WIPO. 536/24.5, 25.1; 435/6, 375, 172.3 WO 94/O2501 2/1994 WIPO. WO 94/17093 8/1994 WIPO. 56) References Cited Primary Examiner John L. LeGuyader U.S. PATENT DOCUMENTS Attorney, Agent, or Firm Woodcock Washburn Kurtz Mackiewicz & Norris LLP 3,687,808 8/1972 Merigan et al.
    [Show full text]
  • Chemistry of Phosphorylated Formaldehyde Derivatives. Part I
    Molecules 2014, 19, 12949-13009; doi:10.3390/molecules190912949 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Chemistry of Phosphorylated Formaldehyde Derivatives. Part I Vasily P. Morgalyuk Laboratory of Organophosphorus Compounds, Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilova str., 28, Moscow 119991, Russia; E-Mail: [email protected]; Tel.: +7-499-135-92-50; Fax: +7-495-135-65-49 Received: 8 July 2014; in revised form: 8 August 2014 / Accepted: 15 August 2014 / Published: 25 August 2014 Abstract: The underinvestigated derivatives of unstable phosphorylated formaldehyde acetals and some of the structurally related compounds, such as thioacetals, aminonitriles, aminomethylphosphinoyl compounds, are considered. Separately considered are halogen aminals of phosphorylated formaldehyde, acetals of phosphorylated formaldehyde of H-phosphinate-type and a phosphorylated gem-diol of formaldehyde. Synthetic methods, chemical properties and examples of practical applications are given. Keywords: phosphorylated acetals; -thioacetals; -aminonitriles; -aminomethylphosphinoyl compounds; -chloro(or bromo)aminals; -gem-dioles; -ketene acetale; H-phosphinate 1. Introduction Among organophosphorus compounds, α-phosphorylated carbonyl compounds stand out by the capacity of cleavage of phosphorus–carbon bond under mild conditions when reacted with nucleophiles [1–5]. The cleavage of phosphorus–carbon bond may proceed spontaneously as well. At the same time, α-oxoalkylphosphinoyl compounds also retain properties inherent in carbonyl compounds, for example, they undergo cross aldol condensation. The least stable compounds among them are phosphorylated formaldehyde derivatives, dialkyl formylphosphonates (1) [6–11] and N,N,N',N'-tetraalkyl formylphosphondiamides (2) [12] (Figure 1), whose existence was even disputed in the first half of the 1970s [13,14].
    [Show full text]
  • 20. Phosphorus Chemistry
    Professor David L. Van Vranken Chemistry 201: Organic Reaction Mechanisms I Topic 20: Phosphorus Chemistry References: Literature cited Phosphorus Functional Groups ■ Here’s how to name phosphorus functional groups: R R R OR R OR O O R P P P R P P(III) R R OR O R phosphine phosphinite phosphonite phosphite (ester) O O O O R R R OR R OR O O P P P R P R P(V) R R OR O R phosphine oxide phosphinate phosphonate phosphate (ester) ■ Few of these functional groups are common. O O O H P N P HO OH O CH HO F 3 glyphosate sarin Phosphorus Functional Groups ■ pKas reveal the difference in basicity between trialkylphosphines and triarylphosphines Et Ph .. + + N N Ph2N Et Et Ph Ph resonance H H reduces l.p. basicity pKa 11 ~ -5 .. Bu Ph Ph P + + 2 P P not so much Bu Bu Ph Ph H H resonance pKa 9 3 ■ Trialkylphosphines are way more nucleophilic than triarylphosphines Bu Ph Bu P: Ph P: Bu Ph way more nucleophilic Howard ST, et al. Can. J. Chem. 1997, 75, 60. Allman, T.; Goel, R. G. Can. J. Chem. 1982, 60, 716.. POCl3 is a Very Reactive Electrophile ■ Old conditions for elimination of OH groups. Contrast the outcomes. SOCl Cl 2 pyridine OH POCl3 pyridine (solvent) ■ Phosphates don’t substitute very quickly, but Cl3P=O is special ■ Vilsmeier-Haack Reaction - amides attack Cl3P=O + NMe O Cl NMe 2 2 E.A.S. MeO + MeO H2O MeO H OMe OMe workup OMe POCl3 + DMF Mechanism for formation of the Vilsmeier reagent: : .
    [Show full text]